Elevated Vascular Endothelial Growth Factor Production in Islets Improves Islet Graft Vascularization
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Successful islet transplantation depends on the infusion of sufficiently large quantities of islets, of which only ∼30% become stably engrafted. Rapid and adequate revascularization of transplanted islets is important for islet survival and function. Delayed and insufficient revascularization can deprive islets of oxygen and nutrients, resulting in islet cell death and early graft failure. To improve islet revascularization, we delivered human vascular endothelial growth factor (VEGF) cDNA to murine islets, followed by transplantation under the renal capsule in diabetic mice. Diabetic animals receiving a marginal mass of 300 islets that were pretransduced with a VEGF vector exhibited near normoglycemia. In contrast, diabetic mice receiving an equivalent number of islets that were transduced with a control vector remained hyperglycemic. Immunohistochemistry with anti-insulin and anti-CD31 antibodies revealed a relatively higher insulin content and greater degree of microvasculature in the VEGF vector–transduced islet grafts, which correlated with significantly improved blood glucose profiles and enhanced insulin secretion in response to glucose challenge in this group of diabetic recipient mice. These results demonstrate that VEGF production in islets stimulates graft angiogenesis and enhances islet revascularization. This mechanism might be explored as a novel strategy to accelerate islet revascularization and improve long-term survival of functional islet mass posttransplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shapiro, A. M. J., Lakey, J. R. T., Ryan, E. A., Korbutt, G. S., Toth, E., Warnock, G. L., Kneteman, N. M., & Rajotte, R. V. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007273430401 · Cited by 5,237
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699 · cited 1×
“Among those factors involved in islet revascularization is vascular endothelial growth factor (VEGF), a key angiogenic molecule that acts to stimulate new vessel formation (15,16).”
Clinical Outcomes and Insulin Secretion After Islet Transplantation With the Edmonton Protocol
Ryan, E. A., Lakey, J. R. T., Rajotte, R. V., Korbutt, G. S., Kin, T., Imes, S., Rabinovitch, A., Elliott, J. F., Bigam, D., Kneteman, N. M., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.4.710 · Cited by 864 · cited 1×
“Islet transplantation is considered a potentially curative treatment for type 1 diabetes (1,2).”
Successful Islet Transplantation
Ryan, E. A., Lakey, J. R. T., Paty, B. W., Imes, S., Korbutt, G. S., Kneteman, N. M., Bigam, D., Rajotte, R. V., & Shapiro, A. M. J. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2148 · Cited by 719
AN IMPROVED METHOD FOR ISOLATION OF MOUSE PANCREATIC ISLETS
GOTOH, M., MAKI, T., KIYOIZUMI, T., SATOMI, S., & MONACO, A. P. (1985) · Transplantation · doi:10.1097/00007890-198510000-00018 · Cited by 533 · cited 1×
“Islets were washed with Hanks’ balanced salt solution, followed by discontinuous Ficoll densitygradient centrifugation as previously described (23).”
Biarnés, M., Montolio, M., Nacher, V., Raurell, M., Soler, J., & Montanya, E. (2002) · Diabetes · doi:10.2337/diabetes.51.1.66 · Cited by 420
Carlsson, P.-O., Palm, F., Andersson, A., & Liss, P. (2001) · Diabetes · doi:10.2337/diabetes.50.3.489 · Cited by 415 · cited 2×
“Insufficient islet revascularization tends to reduce intragraft blood perfusion and oxygen tension (28).”
Isner, J. M. (2002) · Nature · doi:10.1038/415234a · Cited by 309
Mercadier, J.-J., & Logeart, D. (2002) · PubMed · Cited by 305
Hofmann, S. M., Dong, H.-J., Li, Z., Cai, W., Altomonte, J., Thung, S. N., Zeng, F., Fisher, E. A., & Vlassara, H. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2082 · Cited by 296 · cited 1×
“The immunoreactivity was detected using the multilink-HRP ultrasensitive system (BioGenex, San Ramon, CA), as previously described (24).”
Self-citationGraft vascular function after transplantation of pancreatic islets
Jansson, L., & Carlsson, P.-O. (2002) · Diabetologia · doi:10.1007/s00125-002-0827-4 · Cited by 280 · cited 4×
“In contrast, isolated islets are severed from their native vascular network such that after transplantation, the survival and function of islet grafts must depend on the reestablishment of new vessels within the grafts to derive blood flow from the host vascular system (5,6).”
InfluentialConsiderations for successful transplantation of encapsulated pancreatic islets
de Vos, P., Hamel, A. F., & Tatarkiewicz, K. (2002) · Diabetologia · doi:10.1007/s00125-001-0729-x · Cited by 252 · cited 3×
“In addition, intraperitoneally transplanted microencapsulated islets are associated with significantly delayed and diminished responsiveness in releasing insulin after an oral or intravenous glucose challenge (46).”
Cell Loss in Isolated Human Islets Occurs by Apoptosis
Paraskevas, S., Maysinger, D., Wang, R., Duguid, W. P., & Rosenberg, L. (2000) · Pancreas · doi:10.1097/00006676-200004000-00008 · Cited by 229 · cited 1×
“In addition, there is evidence that islet cells undergo apoptosis because of ischemia-reperfusion injury or oxidative stress in islet isolation, contributing to the loss of functional islet mass during the peri-transplant period (30,31).”
Decreased Vascular Density in Mouse Pancreatic Islets After Transplantation
Mattsson, G., Jansson, L., & Carlsson, P.-O. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1362 · Cited by 211 · cited 1×
“This impairment in islet revascularization appears to ensue irrespective of whether islets are transplanted intraportally in the liver, retrogradely into the spleen, or under the kidney capsule (9).”
Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia
Khan, T. A., Sellke, F. W., & Laham, R. J. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301969 · Cited by 123
Rehman, K. K., Bertera, S., Bottino, R., Balamurugan, A. N., Mai, J. C., Mi, Z., Trucco, M., & Robbins, P. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207700200 · Cited by 112
Revascularization and Microcirculation of Freely Grafted Islets of Langerhans
Menger, M. D., Yamauchi, J., & Vollmar, B. (2001) · World Journal of Surgery · doi:10.1007/s002680020345 · Cited by 112 · cited 4×
“Islet revascularization initiates as early as 2–3 days posttransplantation and concludes within 2 weeks (5).”
InfluentialVasir, B., Jonas, J., Steil, G. M., Hollister‐Lock, J., Hasenkamp, W. M., Sharma, A., Bonner‐Weir, S., & Weir, G. C. (2001) · Transplantation · doi:10.1097/00007890-200104150-00018 · Cited by 105 · cited 4×
“This impaired VEGF expression in newly transplanted islets is thought to be a contributing factor for impaired revascularization of transplanted islets in diabetic animals (10,14).”
InfluentialGenetic Engineering of a Suboptimal Islet Graft with A20 Preserves β Cell Mass and Function
Grey, S. T., Longo, C., Shukri, T., Patel, V. I., Csizmadia, E., Daniel, S., Arvelo, M. B., Tchipashvili, V., & Ferran, C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6250 · Cited by 103
Korsgren, O., Jansson, L. E., & Andersson, A. (1989) · Diabetes · doi:10.2337/diab.38.4.510 · Cited by 99
Giannoukakis, N., Mi, Z., Rudert, W. A., Gambotto, A. A., Trucco, M., & Robbins, P. D. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301333 · Cited by 99
Sigrist, S., Mechine-Neuville, A., Mandes, K., Calenda, V., Braun, S., Legeay, G., Bellocq, J.-P., Pinget, M., & Kessler, L. (2003) · Cell Transplantation · doi:10.3727/000000003108747109 · Cited by 95
Association between macrophage activation and function of micro-encapsulated rat islets
de Vos, P., Smedema, I., van Goor, H., Moes, H., Zanten, J. V., Netters, S. J., de Leij, L. F. M., de Haan, A., & de Haan, B. J. (2003) · Diabetologia · doi:10.1007/s00125-003-1087-7 · Cited by 88 · cited 1×
“capsulated islets are still subject to oxidative stress and damage caused by free radicals that are generated from activated immune cells such as macrophages, contributing to islet cell apoptosis and early graft failure (47,48).”
Vasir, B., Reitz, P., Xu, G., Sharma, A., Bonner‐Weir, S., & Weir, G. C. (2000) · Diabetologia · doi:10.1007/s001250051374 · Cited by 87 · cited 1×
“This impaired VEGF expression in newly transplanted islets is thought to be a contributing factor for impaired revascularization of transplanted islets in diabetic animals (10,14).”
Shapiro, A. M. J., Ryan, E. A., & Lakey, J. R. T. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07034-9 · Cited by 83
VASCULAR ENDOTHELIAL GROWTH FACTOR IS INCREASED IN DEVASCULARIZED RAT ISLETS OF LANGERHANS IN VITRO1
Gorden, D. L., Mandriota, S. J., Montesano, R., Orci, L., & Pepper, M. S. (1997) · Transplantation · doi:10.1097/00007890-199702150-00018 · Cited by 82
Human Islet Transplantation: Update
Boker, A., Rothenberg, L. C., Hernandez, C., Kenyon, N. S., Ricordi, C., & Alejandro, R. (2001) · World Journal of Surgery · doi:10.1007/s002680020341 · Cited by 81 · cited 2×
“It is estimated that 30% of islet mass becomes stably engrafted, despite the administration of a large quantity of islets per diabetic recipient (8).”
Öberg-Welsh, C., Sandler, S., Andersson, A., & Welsh, M. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(96)03977-9 · Cited by 81
VEGF Gene Delivery for Treatment of Ischemic Cardiovascular Disease
Koransky, M. L., Robbins, R. C., & Blau, H. M. (2002) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00158-x · Cited by 71
Kawakami, Y., Iwata, H., Gu, Y. J., Miyamoto, M., Murakami, Y., Balamurugan, A. N., Imamura, M., & Inoue, K. (2001) · Pancreas · doi:10.1097/00006676-200111000-00007 · Cited by 70
Zhang, N., Schröppel, B., Chen, D., Fu, S., Hudkins, K. L., Zhang, H., Murphy, B. M., Sung, R. S., & Bromberg, J. S. (2003) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2003.00215.x · Cited by 56 · cited 1×
“Islets were isolated as previously reported (22).”
Self-citationProapoptotic bax is hyperexpressed in isolated human islets compared with antiapoptotic bcl-21
Thomas, D. A., Yang, H., Boffa, D. J., Ding, R., Sharma, V. K., Lagman, M., Li, B., Hering, B. J., Mohanakumar, T., Lakey, J. R. T., et al. (2002) · Transplantation · doi:10.1097/00007890-200212150-00003 · Cited by 49
Dong, H. H., Altomonte, J., Morral, N., Meseck, M. L., Thung, S. N., & Woo, S. L. C. (2002) · Diabetes · doi:10.2337/diabetes.51.1.130 · Cited by 49 · cited 2×
“The recombinant adenoviral vector Ad-EF1 -VEGF expresses the human VEGF165 protein under the control of the elongation factor-1 (EF-1 ) promoter (20).”
Self-citationHepatic insulin expression improves glycemic control in type 1 diabetic rats
Dong, H. H., Morral, N., McEvoy, R. C., Meseck, M. L., Thung, S. N., & Woo, S. L. C. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00220-0 · Cited by 47 · cited 3×
“To prepare adenoviruses, Ad-EF1-VEGF was propagated in HEK293 cells and purified by CsCl density centrifugation as previously described (21).”
InfluentialSelf-citationRobitaille, R., Dusseault, J., Henley, N., Rosenberg, L. C., & Hallé, J. (2003) · Endocrinology · doi:10.1210/en.2002-0185 · Cited by 36
Sylvén, C. (2002) · Drugs of today · doi:10.1358/dot.2002.38.12.820100 · Cited by 34
Encapsulated Islets in Diabetes Treatment
Sambanis, A. (2003) · Diabetes Technology & Therapeutics · doi:10.1089/152091503322250686 · Cited by 31 · cited 1×
“Here, islets are encapsulated in semipermeable membranes with pores of a size allowing passage of nutrients and metabolites (including oxygen, glucose, and insulin) but excluding much larger IgG molecules and lymphocytes, which is meant to protect encapsulated islet cells from autoimmune attack after transplantation i…”
Kusumanto, Y. H., Hospers, G. A. P., Mulder, N., & Tio, R. A. (2003) · International Journal of Cardiovascular Interventions · doi:10.1080/14628840304612 · Cited by 25
&NA; (2003) · Transplantation · doi:10.1097/00007890-200302150-00029 · Cited by 17
Free Radical Profiles in an Encapsulated Pancreatic Cell Matrix Model
Kavdia, M., & Lewis, R. S. (2002) · Annals of Biomedical Engineering · doi:10.1114/1.1481054 · Cited by 12 · cited 1×
“capsulated islets are still subject to oxidative stress and damage caused by free radicals that are generated from activated immune cells such as macrophages, contributing to islet cell apoptosis and early graft failure (47,48).”
Aspects of pancreatic islet transplantation in diabetes mellitus
Hellerström, C., Andersson, A., Korsgren, O., Jansson, L. E., & Sandler, S. (1989) · Baillière s Clinical Gastroenterology · doi:10.1016/0950-3528(89)90037-7 · Cited by 11
Cited by
The Vascular Basement Membrane: A Niche for Insulin Gene Expression and β Cell Proliferation
Nikolova, G., Jabs, N., Konstantinova, I., Domogatskaya, A., Tryggvason, K., Sorokin, L., Fässler, R., Gu, G., Gerber, H.-P., Ferrara, N., et al. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.01.015 · Cited by 511
Brissova, M., Shostak, A., Shiota, M., Wiebe, P. O., Poffenberger, G., Kantz, J., Chen, Z., Carr, C., Jerome, W. G., Chen, J., et al. (2006) · Diabetes · doi:10.2337/db06-0690 · Cited by 442
Zhang, N., Schröppel, B., Lal, G., Jakubzick, C., Mao, X., Chen, D., Yin, N., Jessberger, R., Ochando, J. C., Ding, Y., et al. (2009) · Immunity · doi:10.1016/j.immuni.2008.12.022 · Cited by 411
Self-citationWeaver, J. D., Headen, D. M., Aquart, J., Johnson, C. T., Shea, L. D., Shirwan, H., & García, A. J. (2017) · Science Advances · doi:10.1126/sciadv.1700184 · Cited by 170
In Vivo Immune Modulatory Activity of Hepatic Stellate Cells in Mice
Chen, C.-H., Kuo, L.-M., Chang, Y., Wu, W., Goldbach, C., Ross, M. A., Stolz, D. B., Chen, L., Fung, J. J., Lu, L., et al. (2006) · Hepatology · doi:10.1002/hep.21379 · Cited by 154
Metadata
- Authors
- Zhang, N., Richter, A., Suriawinata, J., Harbaran, S., Altomonte, J., Cong, L., Zhang, H., Song, K., Meseck, M., Bromberg, J., & Dong, H.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2004-04-01
- Volume
- 53
- Issue
- 4
- Pages
- 963-970
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2147243605
- Cited by
- 234
- References
- 42
- FWCI
- 14.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.